Lack of PAI‐1 or alpha‐2 antiplasmin inhibitory actions on fibrinolysis might result in dysregulated or excessive fibrinolysis with resultant signs of a clinical bleeding disorder [33]. The gene discussed is SERPINE1; the disease is hemorrhagic disease.